The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.

The possibility that medroxyprogesterone acetate (MPA) is clinically effective at least in part by its suppression of adrenal steroidogenesis and a resultant reduction of circulating oestrogen levels was investigated in 49 postmenopausal patients with advanced breast cancer. Thirty-one patients were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dowsett, M., Lal, A., Smith, I. E., Jeffcoate, S. L.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1987
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2001763/
https://ncbi.nlm.nih.gov/pubmed/2952154
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars